i10 Productivity
Rankings
Eli Lilly and Company/ Scientists i10 Productivity Rankings 2025
Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Total i10 IndexRankings
Ranking Based On Selection :26
Statistics
Applied statistics in drug discovery
Translational research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
* Total i10 IndexRankings
Ranking Based On Selection :27
Clinical Trials
Inflammatory Bowel Disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
* Total i10 IndexRankings
Ranking Based On Selection :28
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
66
49
0.742
* Total i10 IndexRankings
Ranking Based On Selection :29
Cancer
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
* Total i10 IndexRankings
Ranking Based On Selection :30
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
63
57
0.905
* Total i10 IndexRankings
Ranking Based On Selection :31
Statistics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
62
43
0.694
* Total i10 IndexRankings
Ranking Based On Selection :32
Immunooncology
Myeloid Biology
Angiogenesis
Oncology
Cancer Therapeutics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
40
0.714
* Total i10 IndexRankings
Ranking Based On Selection :33
structural biology
computational biology
structural bioinformatics
biophysics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
27
0.482
* Total i10 IndexRankings
Ranking Based On Selection :34
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
55
47
0.855
* Total i10 IndexRankings
Ranking Based On Selection :35
Health Outcomes
Real World Evidence
Pain
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
42
0.792
* Total i10 IndexRankings
Ranking Based On Selection :36
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
40
0.755
* Total i10 IndexRankings
Ranking Based On Selection :37
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
29
0.547
* Total i10 IndexRankings
Ranking Based On Selection :38
Quality of life research
Patient-reported outcomes
Health economics
Cancer
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
52
47
0.904
* Total i10 IndexRankings
Ranking Based On Selection :39
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
51
39
0.765
* Total i10 IndexRankings
Ranking Based On Selection :40
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
50
23
0.460
* Total i10 IndexRankings
Ranking Based On Selection :41
Bayesian Statistics
Clinical Trials
Survival Analysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
41
0.837
* Total i10 IndexRankings
Ranking Based On Selection :42
cancer cure and business
power of brain
VR and AI
extreme sports psychology and sociology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
27
0.574
* Total i10 IndexRankings
Ranking Based On Selection :43
Biotechnology
Drug Discovery
Chemical Biology
Glycobiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
42
0.933
* Total i10 IndexRankings
Ranking Based On Selection :44
Drug discovery
organic chemistry
continuous flow chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
38
0.864
* Total i10 IndexRankings
Ranking Based On Selection :45
Drug Discovery & Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
18
0.409
* Total i10 IndexRankings
Ranking Based On Selection :46
Analytical Chemistry
Toxicology
Mass Spectrometry
Chemometrics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
36
0.857
* Total i10 IndexRankings
Ranking Based On Selection :47
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
30
0.732
* Total i10 IndexRankings
Ranking Based On Selection :48
Statistics
clinical trials
health outcomes research
Bayesian methods
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
23
0.561
* Total i10 IndexRankings
Ranking Based On Selection :49
Clinical trial design
missing data
generalized linear models
surrogate marker
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
22
0.537
* Total i10 IndexRankings
Ranking Based On Selection :50
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
50
33
0.660
Richard E Higgs
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
Statistics
Applied statistics in drug discovery
Translational research
Klaus Gottlieb
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
Sreekumar Pillai
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
66
49
0.742
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
Louis F Stancato
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
Andrew C Adams
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
63
57
0.905
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
Ilya Lipkovich
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
62
43
0.694
Sudhakar Reddy Chintharlapalli
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
40
0.714
Immunooncology
Myeloid Biology
Angiogenesis
Oncology
Cancer Therapeutics
J Michael Sauder
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
27
0.482
structural biology
computational biology
structural bioinformatics
biophysics
Mallikarjuna Rettiganti
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
55
47
0.855
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
Rebecca L Robinson
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
42
0.792
James W Perfield Ii
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
40
0.755
Robert W Siegel
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
29
0.547
Nalin Payakacha
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
52
47
0.904
Quality of life research
Patient-reported outcomes
Health economics
Cancer
Salvador Garcia Munoz
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
51
39
0.765
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
David Cox
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
50
23
0.460
Haoda Fu
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
41
0.837
Bayesian Statistics
Clinical Trials
Survival Analysis
Michal Vieth
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
27
0.574
cancer cure and business
power of brain
VR and AI
extreme sports psychology and sociology
Henning Stöckmann
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
42
0.933
Biotechnology
Drug Discovery
Chemical Biology
Glycobiology
Carlos Mateos
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
38
0.864
Drug discovery
organic chemistry
continuous flow chemistry
Chafiq Hamdouchi
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
18
0.409
Valentina Pirro
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
36
0.857
Analytical Chemistry
Toxicology
Mass Spectrometry
Chemometrics
Olivier Benichou
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
30
0.732
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
Wei Shen
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
23
0.561
Statistics
clinical trials
health outcomes research
Bayesian methods
Yongming Qu
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
22
0.537
Clinical trial design
missing data
generalized linear models
surrogate marker
Prashant Desai
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
50
33
0.660